Crane Biosciences
Red blood cell-derived nanoparticle platform for brain mRNA delivery.
Crane Biosciences engineers red blood cell–based nanoparticles to transport nucleic acid therapeutics across the blood-brain barrier—supporting precise, minimally invasive delivery for neurological diseases.
Founders
Luca Bolondi
CEO
Luca was team member #5 at successful deeptech startup, Moi Composites. He then worked in healthcare investing at Italian Mezzanine, a $100M PE fund.
Sujaan Das
CTO
Sujaan is a red blood cell biochemistry expert with a PhD from the Francis Crick Institute. He led a research group at LMU Munich as a Marie Curie Fellow.